Phenylephrine pharmacokinetics
Pro Research Analysisby 
Searched over 200M research papers for "phenylephrine pharmacokinetics"
Phenylephrine Pharmacokinetics: Absorption, Distribution, Metabolism, and Excretion
Oral Absorption and Bioavailability of Phenylephrine
Phenylephrine is rapidly absorbed after oral administration, with peak plasma concentrations (Tmax) typically reached within 0.17 to 1.5 hours in both adults and children. However, its oral bioavailability is low, around 38%, due to significant first-pass metabolism in the gut and liver. Only a small fraction of the orally administered dose appears as free phenylephrine in the bloodstream, with most being metabolized before reaching systemic circulation Gelotte2015Gelotte2022Hengstmann1982+1 MORE.
Dose-Dependent Pharmacokinetics
Systemic exposure to phenylephrine, measured by maximum concentration (Cmax) and area under the curve (AUC), increases disproportionately with higher doses. For example, in adults, single oral doses of 10, 20, and 30 mg result in mean Cmax values of 1354, 2959, and 4492 pg/mL, respectively, and AUC values of 955.8, 2346, and 3900 pg·h/mL. This non-linear increase suggests saturation of metabolic pathways at higher doses .
Elimination and Half-Life
Phenylephrine has a short elimination half-life, typically ranging from 1.2 to 3 hours in both adults and children. Total clearance is about 2 L/h, and the volume of distribution is approximately 340 L, similar to other structurally related amines Gelotte2022Hengstmann1982Hengstmann1982.
Metabolism and Excretion
Phenylephrine is extensively metabolized, primarily through sulfation and, to a lesser extent, glucuronidation. The main metabolite in urine after oral administration is phenylephrine sulfate, while 3-hydroxymandelic acid is more prominent after intravenous administration. Only negligible amounts of unchanged phenylephrine and its glucuronide are excreted in urine, indicating efficient metabolic conversion Gelotte2015Gelotte2022Hengstmann1982+2 MORE.
Factors Affecting Phenylephrine Pharmacokinetics
- Co-administration with Acetaminophen: When phenylephrine is taken with acetaminophen, its bioavailability can double due to competition for presystemic sulfation, leading to higher plasma concentrations and increased urinary excretion of phenylephrine sulfate Gelotte2018Atkinson2015.
- Salt Form and Food: The tannate salt form of phenylephrine slows absorption compared to the hydrochloride salt, but does not extend the duration of action. Food delays absorption but does not affect the total amount absorbed .
- Pediatric Considerations: In children, oral clearance increases with age, but when adjusted for body size, younger children have slightly higher scaled clearance. Pharmacokinetics and metabolism in children are consistent with adults, though systemic exposure is somewhat lower in the youngest age group .
Special Considerations: Dermal Application and Vasoconstriction
When applied dermally, phenylephrine’s vasoconstrictive properties can reduce systemic absorption of co-applied drugs by decreasing local blood flow, thereby increasing local tissue concentrations and reducing systemic exposure .
Conclusion
Phenylephrine is rapidly absorbed but has low oral bioavailability due to extensive first-pass metabolism. Its pharmacokinetics are dose-dependent and influenced by co-administered drugs, salt form, and food. Metabolism primarily occurs via sulfation, with minimal unchanged drug excreted in urine. These characteristics are consistent across adults and children, with minor differences in systemic exposure and clearance. Overall, phenylephrine is well tolerated, with predictable pharmacokinetic behavior under most conditions Gelotte2015Gelotte2022Hengstmann1982+4 MORE.
Sources and full results
Most relevant research papers on this topic